Role of the E2F1-p19ARF-p53 pathway in ischemic acute renal failure

Nephron - Physiology

Volumn 101, Issue 2, 2005, Pages 27-34

  Tanaka, Hiroyuki ^a   Terada, Yoshio ^a   Okado, Tomokazu ^a   Inoshita, Seiji ^a   Kuwahara, Michio ^a   Sasaki, Sei ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cell cycle; Ischemia; Renal tubule

Indexed keywords

PROTEIN P19; PROTEIN P53; TRANSCRIPTION FACTOR E2F1;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL STRAIN; CONTROLLED STUDY; EXPRESSION VECTOR; GENE OVEREXPRESSION; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY MEDULLA; KIDNEY TUBULE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; E2F1 TRANSCRIPTION FACTOR; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 23944504274     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086642     Document Type: Article

References (45)

1. Shimizu A, Yamanaka N: Apoptosis and cell desquamation in repair process of ischemic tubular necrosis. Virchows Arch B Cell Pathol Incl Mol Pathol 1993;64:171-180.
2. Bonventre JV: Mechanisms of ischemic acute renal failure. Kidney Int 1993;43:1160-1178.
3. Molitoris BA: Ischemic acute renal failure: exciting times at our fingertips. Curr Opin Nephrol Hypertens 1998;7:405-406.
4. Shankland SJ: Cell-cycle control and renal disease. Kidney Int 1997;52:294-308.
5. Megyesi J, Udvarhelyi N, Safirstein RL, Price PM: The p53-independent activation of transcription of p21 WAF1/CIP1/SDI1 after acute renal failure. Am J Physiol 1996;27:F1211-F1216.
6. Megyesi J, Safirstein RL, Price PM: Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 1998;101:777-782.
7. Park SK, Kang MJ, Kim W, Koh GY: Renal tubule regeneration after ischemic injury is coupled to the up-regulation and activation of cyclins and cyclin dependent kinases. Kidney Int 1997;52:706-714.
8. Terada Y, Tanaka H, Okado T, Shimamura H, Inoshita S, Kuwahara M, Sasaki S: Expression and function of the developmental gene Wnt-4 during experimental acute renal failure in rats. J Am Soc Nephrol 2003;14:1223-1233.
9. Hunter T, Pines J: Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Saibo 1994;79:573-582.
10. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ: Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 1993;7:331-342.
11. Sherr CJ: Mammalian G1 cyclins. Cell 1993;73:1059-1065.
12. Sherr CJ: Cancer cell cycles. Science 1996;274:1672-1677.
13. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kalo J, Livingston DM: Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 1993;73:487-497.
14. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 1995;81:323-330.
15. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR: Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 1997;94:7245-7250.
16. Morgenbesser SD, Williams BO, Jacks T, DePinho RA: p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994;371:72-74.
17. Nevins JR: E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992;258:424-429.
18. Nevins JR: Toward an understanding of the functional complexity of the E2F and retino-blastoma families. Cell Growth Differ 1998;9:585-593.
19. Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL, Vousden KH: p14ARF links the tumour suppressors RB and p53. Nature 1998;395:124-125.
20. Inoue K, Roussel MF, Sherr CJ: Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1. Proc Natl Acad Sci USA 1999;96:3993-3998.
21. Robertson KD, Jones PA: The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol Cell Biol 1998;18:6457-6473.
22. Quelle DE, Zindy F, Ashmun RA, Sherr CJ: Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995;83:993-1000.
23. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G, Kamb A: Complex structure and regulation of the P16 (MTS1) locus. Cancer Res 1995;55:2988-2994.
24. Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ, Sidransky D: A novel p16INK4A transcript. Cancer Res 1995;55:2995-2997.
25. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ: Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997;91:649-659.
26. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-707.
27. Serrano M: The INK4a/ARF locus in murine tumorigenesis. Carcinogenesis 2000;21:865-869.
28. Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C, DePinho RA: The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998;92:713-723.
29. Zhang Y, Xiong Y, Yarbrough WG: ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 1998;92:725-734.
30. Kurokawa K, Tanaka T, Kato J: p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts. Oncogene 1999;18:2718-2727.
31. Schwarz JK, Bassing CH, Kovesdi I, Datto MB, Blazing M, George S, Wang XF, Nevins JR: Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression. Proc Natl Acad Sci USA 1995;92:483-487.
32. Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sakaki T, Sugano S, Saito I: Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res 1995;23:3816-3821.
33. Terada Y, Yamada T, Nakashima O, Tamamori M, Ito H, Sasaki S, Marumo F: Overexpression of cell cycle inhibitors (p16INK4 and p21Cip1) and cyclin D1 using adenovirus vectors regulates proliferation of rat mesangial cells. J Am Soc Nephrol 1997;8:51-60.
34. Terada Y, Nakashima O, Inoshita S, Kuwahara M, Sasaki S, Marumo F: TGF-β-activating kinase-1 inhibits cell cycle and expression of cyclin D1 and A in LLC-PK1 cells. Kidney Int 1999;56:1378-1390.
35. Herzlinger DA, Easton TG, Ojakian GK: The MDCK epithelial cell line expresses a cell surface antigen of the kidney distal tubule. J Cell Biol 1982;93:269-277.
36. Yokoo T, Kitamura M: Unexpected protection of glomerular mesangial cells from oxidant-triggered apoptosis by bioflavonoid quercetin. Am J Physiol 1997;273:F206-F212.
37. Terada Y, Inoshita S, Kanada S, Shimamura H, Kuwahara M, Ogawa W, Kasuga M, Sasaki S, Marumo F: Hyperosmolality activates Akt and regulates apoptosis in renal tubular cells. Kidney Int 2001;60:553-567.
38. Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW, DePinho RA: Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 2001;413:86-91.
39. Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A: Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 2001;413:83-86.
40. Sherr CJ: The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2001;2:731-737.
41. Witzgall R, Brown D, Schwarz C, Bonventre JV: Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. J Clin Invest 1994;93:2175-2188.
42. Megyesi J, Andrade L, Vieira Jr JM, Safirstein RL, Price PM: Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure. Kidney Int 2001;60:2164-2172.
43. DeGregori J, Kowalik T, Nevins JR: Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol 1995;15:4215-4224.
44. Lieberthal W, Nigam SK: Acute renal failure. I. Relative importance of proximal vs. distal tubular injury. Am J Physiol 1998;275:F623-F631.
45. Brezis M, Rosen S: Hypoxia of the renal medulla-its implications for disease. N Engl J Med 1995;332:647-655.